Results 1 to 10 of about 821,037 (255)

Frequency of thrombocytopenia in severe COVID-19

Pakistan Journal of Pharmaceutical Sciences, 2022
To aim of the study was to determine the frequency of thrombocytopenia and its effect on clinical outcomes in South Asian patients admitted with severe COVID-19.
Mehak Hanif, Kamran Khan Sumalani, Zarkesh Shaikh, Vishal Mandhan, Shahbaz Haider   +4 more
doaj   +1 more source

Ventilator-associated events: From surveillance to optimizing management

Journal of Intensive Medicine, 2023
Mechanical ventilation (MV) is a life-support therapy that may predispose to morbid and lethal complications, with ventilator-associated pneumonia (VAP) being the most prevalent.
Sergio Ramirez-Estrada, Yolanda Peña-Lopez, Tarsila Vieceli, Jordi Rello   +3 more
doaj   +1 more source

New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants

BMC Medicine, 2023
As new, efficacious respiratory syncytial virus (RSV) immunization products reach the market, affordable pricing as well as improved estimation of disease burden and the full potential and cost effectiveness of RSV prevention in the hardest hit ...
Padmini Srikantiah, Keith P. Klugman
doaj   +1 more source

Candida species in community-acquired pneumonia in patients with chronic aspiration

Pneumonia, 2021
Background When Candida species is found in a sputum culture, clinicians generally dismiss it as a contaminant. We sought to identify cases of community-acquired pneumonia (CAP) in which Candida might play a contributory etiologic role.
Benjamin J. Moss, Daniel M. Musher
doaj   +1 more source

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England

Pneumonia, 2023
Background Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates (IRs) in ...
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Ian Matthews, Eric Sarpong, Alessandra Lacetera, Nawab Qizilbash   +6 more
doaj   +1 more source

Risk factors for childhood pneumonia at Adama Hospital Medical College, Adama, Ethiopia: a case-control study

Pneumonia, 2022
Background Pneumonia is an acute respiratory infection of the lungs. A child dies of pneumonia every 39 s globally. Even though pneumonia affects children worldwide, the risk and repercussions of the disease are more prevalent in poor and middle-income ...
Tsega-Ab Abebaw, William Kiros Aregay, Mulu Tugi Ashami   +2 more
doaj   +1 more source

Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection

Pneumonia, 2023
Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that PCVs also reduce pneumonia and lower respiratory tract infections (LRTIs) more broadly ...
Eileen M. Dunne, Marta C. Nunes, Mary P. E. Slack, Christian Theilacker, Bradford D. Gessner   +4 more
doaj   +1 more source

Innate immune responses in pneumonia

Pneumonia, 2023
The lungs are an immunologically unique environment; they are exposed to innumerable pathogens and particulate matter daily. Appropriate clearance of pathogens and response to pollutants is required to prevent overwhelming infection, while preventing ...
Filiz T. Korkmaz, Katrina E. Traber
doaj   +1 more source

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

Pneumonia, 2021
COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients.
Anolin Aslan, Cynthia Aslan, Naime Majidi Zolbanin, Reza Jafari   +3 more
doaj   +1 more source

Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia

Pneumonia, 2017
Background Patients with recurrent respiratory tract infections and an impaired response to pneumococcal polysaccharide vaccination are diagnosed with a specific antibody deficiency.
Diana van Kessel, Thijs Hoffman, Heleen van Velzen-Blad, Bob Meek, Suzan van Mens, Jan Grutters, Ger Rijkers   +6 more
doaj   +1 more source